TORISEL is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. (1) The recommended dose of TORISEL is 25 mg administered as an intravenous infusion over a 30–60 minute period once a week. Treat until disease progression or unacceptable toxicity. (2.1) TORISEL injection, 25 mg/mL supplied with DILUENT for TORISEL. (3)

Temsirolimus, sold under the brand name Torisel, is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in May 2007, [3] and was also approved by the European Medicines Agency (EMA) in November 2007. [1]

TORISEL is administered as an intravenous infusion over a 30- to 60-minute period once weekly. The use of an infusion pump is the preferred method of administration to ensure accurate delivery of the product.

Aug 23, 2023 · Torisel is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Torisel is used to treat cancer of the kidneys, also called renal cell carcinoma. Torisel may also be used for purposes not listed in this medication guide.

Find TORISEL® medical information: Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Mar 25, 2025 · TORISEL ® is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma. (1) The recommended dose of TORISEL is 25 mg administered as an intravenous infusion over a 30–60 minute period once a week. Treat until disease progression or unacceptable toxicity. (2.1) TORISEL injection, 25 mg/mL supplied with DILUENT for TORISEL. (3)

Visit www.torisel.com. Pfizer Oncology Together™ provides financial assistance resources to help patients access their prescribed Oncology medicines. TORISEL - U.S. Medical Information Page - patient information, ways to contact Pfizer Medical & other resources; for Healthcare professionals: TORISEL U.S. Physician Prescribing Information

Torisel is a medicine used to treat patients with the following types of cancer: advanced renal cell carcinoma (a kidney cancer). ‘Advanced’ means that the cancer has started to spread;

It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. What should I tell my care team before I take this medication? This medication is infused into a vein.

TORISEL is an inhibitor of mTOR approved in the European Union for the first-line treatment of patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors. TORISEL demonstrated a statistically significant increase in median overall survival (OS) compared with IFN-α.